<VariationArchive VariationID="1069931" VariationName="NM_006306.4(SMC1A):c.10del (p.Phe3_Leu4insTer)" VariationType="Deletion" Accession="VCV001069931" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1065466" VariationID="1069931">
      <GeneList>
        <Gene Symbol="SMC1A" FullName="structural maintenance of chromosomes 1A" GeneID="8243" HGNC_ID="HGNC:11111" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="53374149" stop="53422728" display_start="53374149" display_stop="53422728" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="53401069" stop="53449617" display_start="53401069" display_stop="53449617" Strand="-" />
          </Location>
          <OMIM>300040</OMIM>
          <Haploinsufficiency last_evaluated="2018-07-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMC1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-07-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMC1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006306.4(SMC1A):c.10del (p.Phe3_Leu4insTer)</Name>
      <CanonicalSPDI>NC_000023.11:53422590:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="53422591" stop="53422591" display_start="53422591" display_stop="53422591" variantLength="1" positionVCF="53422590" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="53449540" stop="53449540" display_start="53449540" display_stop="53449540" variantLength="1" positionVCF="53449539" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_773" sequenceAccession="LRG_773">
            <Expression>LRG_773:g.5080del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_773t1" sequenceAccession="LRG_773t1">
            <Expression>LRG_773t1:c.-203del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033076.2" sequenceAccession="NG_033076" sequenceVersion="2" change="g.4738del">
            <Expression>NG_033076.2:g.4738del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001281463.1" sequenceAccession="NM_001281463" sequenceVersion="1" change="c.-203del">
            <Expression>NM_001281463.1:c.-203del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006306.4" sequenceAccession="NM_006306" sequenceVersion="4" change="c.10del" MANESelect="true">
            <Expression>NM_006306.4:c.10del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006297.2" sequenceAccession="NP_006297" sequenceVersion="2" change="p.Phe3_Leu4insTer">
            <Expression>NP_006297.2:p.Phe3_Leu4insTer</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.53449541del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.53449541del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.53422592del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.53422592del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_006988.2" sequenceAccession="NG_006988" sequenceVersion="2" change="g.5080del">
            <Expression>NG_006988.2:g.5080del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2146614137" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006306.4(SMC1A):c.10del (p.Phe3_Leu4insTer) AND Congenital muscular hypertrophy-cerebral syndrome" Accession="RCV001381926" Version="4">
        <ClassifiedConditionList TraitSetID="3183">
          <ClassifiedCondition DB="MedGen" ID="C1802395">Congenital muscular hypertrophy-cerebral syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-08-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-08-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26386245</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27334371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28166369</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28548707</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31334757</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3183" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4850" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital muscular hypertrophy-cerebral syndrome</ElementValue>
                <XRef ID="Congenital+muscular+hypertrophy-cerebral+syndrome/8077" DB="Genetic Alliance" />
                <XRef ID="55016009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cornelia de Lange syndrome 2</ElementValue>
                <XRef ID="MONDO:0010370" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CDLS2</ElementValue>
                <XRef Type="MIM" ID="300590" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15259" />
                <XRef ID="15259" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C1802395" DB="MedGen" />
              <XRef ID="MONDO:0010370" DB="MONDO" />
              <XRef Type="MIM" ID="300590" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3106113" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="10493421|MedGen:C1802395" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001580501" DateUpdated="2024-02-28" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-08-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26386245</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27334371</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28166369</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28548707</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31334757</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Leu4*) in the SMC1A gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with SMC1A-related conditions. Loss-of-function variants in SMC1A are known to be pathogenic (PMID: 26386245, 27334371, 28166369, 28548707, 31334757). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMC1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.53449540del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1802395" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3106113" TraitType="Disease" MappingType="XRef" MappingValue="C1802395" MappingRef="MedGen">
        <MedGen CUI="C1802395" Name="Congenital muscular hypertrophy-cerebral syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

